Tenaya Therapeutics reports interim RIDGE-1 data showing reduced arrhythmia burden with TN-401

SN BioScience reports first patient dosed in global Phase 1b/2 clinical trial of SNB-101

Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award

AstraZeneca reports survival gains in Phase III bladder cancer trial

Ipsen presents Phase II corabotase data at SCALE 2026 symposium

SOPHiA GENETICS and Synnovis partner to expand NHS liquid biopsy testing

Voyager Technologies secures ISS mission management contract with Exobiosphere

Kelun-Biotech's SKB118 PD-1 x VEGF bispecific antibody receives Chinese regulatory Investigational New Drug approval

WuXi Biologics named in 2026 Dow Jones Best-in-Class World Index and Emerging Markets Index

Clearway Health recognised with 2026 Great Place To Work Certification for fourth consecutive year

Servier's Emi-Le receives US FDA breakthrough therapy designation for adenoid cystic carcinoma

Insilico Medicine enters strategic collaboration agreement with Ribo

Bavarian Nordic secures USD97m US vaccine contract expansion and raises 2026 outlook

Cellular Intelligence and Novo Nordisk enter agreement to advance clinical-stage Parkinson's cell therapy

Ranok Therapeutics reports positive Phase 1a clinical results for KRAS G12D inhibitor RNK08954